Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phospholipase A2 (phosphatide acylhydrolase, EC 3.1.1.4) from porcine pancreas.

× No keyword cloud information.

21 in total

1. Purification and characterization of a potent hemolytic toxin with phospholipase A2 activity from the venom of Indian Russell's viper.

Authors: Amit K Chakraborty; Robert H Hall; Asoke C Ghose
Journal: Mol Cell Biochem Date: 2002-08 Impact factor: 3.396

2. Surface dilution kinetics using substrate analog enantiomers as diluents: enzymatic lipolysis by bee venom phospholipase A2.

Authors: Jasmeet Singh; Radha Ranganathan; Joseph Hajdu
Journal: Anal Biochem Date: 2010-08-19 Impact factor: 3.365

3. ATPase and phosphatase activities from human red cell membranes: II. The effects of phospholipases on Ca2+-dependent enzymic activities.

Authors: D E Richards; J C Vidal; P J Garrahan; A F Rega
Journal: J Membr Biol Date: 1977-06-30 Impact factor: 1.843

4. Purification of apo-3-D-(-) hydroxybutyrate dehydrogenase from rat liver mitochondria.

Authors: J C Vidal; E A Guglielmucci; A O Stoppani
Journal: Mol Cell Biochem Date: 1977-07-05 Impact factor: 3.396

5. Asp-49 is not an absolute prerequisite for the enzymic activity of low-M(r) phospholipases A2: purification, characterization and computer modelling of an enzymically active Ser-49 phospholipase A2, ecarpholin S, from the venom of Echis carinatus sochureki (saw-scaled viper).

Authors: J Polgár; E M Magnenat; M C Peitsch; T N Wells; K J Clemetson
Journal: Biochem J Date: 1996-11-01 Impact factor: 3.857

6. Critical micelle concentrations and stirring are rate limiting in the loss of lipid mass during membrane degradation by phospholipase A2.

Authors: H Speijer; P L Giesen; R F Zwaal; C E Hack; W T Hermens
Journal: Biophys J Date: 1996-05 Impact factor: 4.033

7. Enzymes of phospholipid metabolism in airway secretions of patients with asthma, cystic fibrosis, and alveolar proteinosis.

Authors: S Sahu; W S Lynn
Journal: Inflammation Date: 1977-06 Impact factor: 4.092

8. Chemical modification and inactivation of phospholipases A2 by a manoalide analogue.

Authors: S Fujii; Y Tahara; M Toyomoto; S Hada; H Nishimura; S Inoue; K Ikeda; Y Inagaki; S Katsumura; Y Samejima
Journal: Biochem J Date: 1995-05-15 Impact factor: 3.857

9. Intestinal phospholipase, a novel enzyme.

Authors: C M Mansbach; G Pieroni; R Verger
Journal: J Clin Invest Date: 1982-02 Impact factor: 14.808

10. Enzymatic modification of plasma low density lipoproteins in rabbits: a potential treatment for hypercholesterolemia.

Authors: R Labeque; C J Mullon; J P Ferreira; R S Lees; R Langer
Journal: Proc Natl Acad Sci U S A Date: 1993-04-15 Impact factor: 11.205